Log In or Register to Join The Conversation!
Viewing 0 reply threads
  • Author
    • #12298

      Treprostinil — a vasodilator —  was approved by the U.S. Food and Drug Administration (FDA) in 2002 for the treatment of pulmonary arterial hypertension. The drug is commercially available as Tyvaso, Orenitram, and Remodulin.

      A Phase 1 clinical trial (NCT03464864) found that treprostinil can be safely delivered at varying doses using Technosphere, a novel inhalation device, MannKind, the device’s developer, announced.

      Read more about this clinical trial here: Treprostinil Delivered Using Technosphere Portable Inhaler Seen as Safe in Early Clinical Trial

      Have you heard of Treprostinil or any of its commercial names? What do you think of this trial’s findings?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.
Copyright © 2017-2021 All rights reserved.

©2021 KLEO Template a premium and multipurpose theme from Seventh Queen


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials


Forgot your details?


Create Account